myeloproliferative neoplasms
Conditions
Interventions
None listed
Sponsors
Mie University, Department of Hematology and Oncology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: myeloproliferative neoplasms
Exclusion criteria
Exclusion criteria: Patients without informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| frequencies of each genetic abnormalities, clinical presentations, prognosis in myeloproliferative neoplasms | — |
Countries
Japan
Contacts
Public ContactYuka Sugimoto
Mie University Department of Hematology and Oncology
Outcome results
None listed